Author(s): HaibeKains B, ElHachem N, Birkbak NJ, Jin AC, Beck AH,
Abstract Share this page
Abstract Two large-scale pharmacogenomic studies were published recently in this journal. Genomic data are well correlated between studies; however, the measured drug response data are highly discordant. Although the source of inconsistencies remains uncertain, it has potential implications for using these outcome measures to assess gene-drug associations or select potential anticancer drugs on the basis of their reported results.
This article was published in Nature
and referenced in Gene Technology